Eli Lilly is planning to increase its pharmaceutical production in the United States by building four new facilities. This expansion could involve the production of well-known medications like Trulicity and Jardiance.
The company’s decision boosts its total investment promises in the U.S. to over $50 billion since 2020. Unfortunately, the text doesn’t provide specific names of pills or medications.